DHX9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.057000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.608610E-01
Normal-vs-Stage2
4.087600E-01
Normal-vs-Stage3
2.644400E-01
Normal-vs-Stage4
9.221600E-01
Stage1-vs-Stage2
6.174600E-01
Stage1-vs-Stage3
4.959200E-01
Stage1-vs-Stage4
3.111400E-01
Stage2-vs-Stage3
1.925960E-01
Stage2-vs-Stage4
4.311000E-01
Stage3-vs-Stage4
2.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.885200E-01
Normal-vs-AfricanAmerican
7.261000E-01
Normal-vs-Asian
3.457600E-01
Caucasian-vs-AfricanAmerican
1.024020E-01
Caucasian-vs-Asian
6.715200E-01
AfricanAmerican-vs-Asian
1.110380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.746000E-01
Normal-vs-Female
3.408200E-01
Male-vs-Female
5.616600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.225400E-01
Normal-vs-Age(41-60Yrs)
5.757000E-01
Normal-vs-Age(61-80Yrs)
3.726200E-01
Normal-vs-Age(81-100Yrs)
2.351600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.865410E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.203600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.273000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.078100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.000800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.188600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.033400E-01
Normal-vs-Daily Drinker
3.279400E-01
Normal-vs-Weekly Drinker
3.457200E-01
Normal-vs-Occasional Drinker
8.802800E-01
Normal-vs-Social Drinker
3.778800E-01
Non Drinker-vs-Daily Drinker
9.181800E-01
Non Drinker-vs-Weekly Drinker
9.907400E-01
Non Drinker-vs-Occasional Drinker
1.367620E-02
Non Drinker-vs-Social Drinker
6.791800E-01
Daily Drinker-vs-Weekly Drinker
9.431200E-01
Daily Drinker-vs-Occasional Drinker
1.565880E-02
Daily Drinker-vs-Social Drinker
6.450800E-01
Weekly Drinker-vs-Occasional Drinker
3.205700E-02
Weekly Drinker-vs-Social Drinker
7.189200E-01
Occasional Drinker-vs-Social Drinker
4.887800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.300030E-01
Normal-vs-Grade 2
5.634000E-01
Normal-vs-Grade 3
5.202600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.210200E-01
Grade 1-vs-Grade 3
2.170200E-01
Grade 1-vs-Grade 4
1.300030E-01
Grade 2-vs-Grade 3
1.425780E-01
Grade 2-vs-Grade 4
5.634000E-01
Grade 3-vs-Grade 4
5.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.586000E-01
Normal-vs-NonDiabetic
3.958600E-01
Diabetic-vs-NonDiabetic
1.637210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.185830E-01
Normal-vs-NoPancreatitis
3.995000E-01
Pancreatitis-vs-NoPancreatitis
5.743800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.605600E-01
Normal-vs-N1
4.148000E-01
N0-vs-N1
4.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.854200E-01
Normal-vs-TP53-NonMutant
4.766600E-01
TP53-Mutant-vs-TP53-NonMutant
1.001980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
